Table 2– Baseline characteristics of all patients and subgroups according to the aetiology of pulmonary arterial hypertension
All patientsAetiologyp-value#
IPAHCTDPH
Patients n1378651
Age yrs60 (22)60 (29)62 (13)0.18
Females95 (69)54 (63)41 (80)<0.05
Lung function % pred
 FEV187 (22)88 (19)85 (24)0.84
 FVC99 (23)101 (22)98 (32)0.48
DL,CO43 (32)45 (38)41 (18)0.22
WHO FC
 I and II22 (16)17 (20)5 (10)<0.05
 III104 (76)59 (69)45 (88)
 IV11 (8)10 (12)1 (2)
Haemodynamics
ra mmHg6 (7)6 (7)7 (8)0.40
pa mmHg48 (19)50 (18)42 (19)<0.01
 CI L·min−1·m−22.1 (0.9)2.2 (0.9)2.0 (0.9)0.92
 PVR Wood units10.5 (8.4)10.6 (7.8)9.7 (9.9)0.36
SV,O2 %63±864±863±90.60
6MWD+
 Absolute 6MWD m264±111271±117251±1020.33
 6MWD % pred
  Enright 1150±1950±2050±190.95
  Troosters 1341±1641±1642±150.84
  Gibbons 1241±1641±1640±150.81
  Chetta 1049±1949±2049±180.92
  • Data are expressed as mean±sd or n (%), unless otherwise stated; : median (interquartile range). IPAH: idiopathic pulmonary arterial hypertension; CTDPH: connective tissue disease-associated pulmonary hypertension; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; DL,CO: diffusing capacity of the lung for carbon monoxide; WHO FC: World Health Organization functional class; ra: mean right atrial pressure; pa: mean pulmonary artery pressure; CI: cardiac index; PVR: pulmonary vascular resistance; SV,O2: mixed venous oxygen saturation; 6MWD: 6-min walk distance. #: comparing IPAH versus CTDPH patients; +: n = 130.